Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.07.080
Abstract: BACKGROUND In patients with disabling symptoms caused by hypertrophic obstructive cardiomyopathy (HOCM), echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) could be a less invasive treatment option. OBJECTIVES This study aimed to investigate the safety and…
read more here.
Keywords:
intramyocardial septal;
percutaneous intramyocardial;
hypertrophic obstructive;
septal radiofrequency ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "BMC Cardiovascular Disorders"
DOI: 10.1186/s12872-025-05002-1
Abstract: Percutaneous endocardial septal radiofrequency ablation (PESA) shows promise as a treatment for hypertrophic obstructive cardiomyopathy (HOCM). We aimed to explore the efficacy and safety of PESA require further study during a long-term follow-up. We enrolled…
read more here.
Keywords:
endocardial septal;
hypertrophic obstructive;
radiofrequency ablation;
percutaneous endocardial ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal of Cardiothoracic Surgery"
DOI: 10.1186/s13019-024-02934-1
Abstract: Background The feasibility of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) for the treatment of hypertrophic obstructive cardiomyopathy (HOCM) has been previously reported. However, limited investigation has been conducted regarding the complications associated with this procedure.…
read more here.
Keywords:
risk;
intramyocardial septal;
septal radiofrequency;
risk factors ... See more keywords